Xenon Pharmaceuticals Inc.
XENE | NASDAQ
$38.67
-$0.32 (-0.82%)
Sep 22, 2026, 1:23 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 7.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 132K | 536K | 8.77M | 3.74M | 8.12M | 2.22M | 4.36M |
Cost of Revenue | n/a | n/a | 611K | 77.05M | 632K | n/a | n/a | n/a | n/a | 599K | n/a | n/a | n/a | n/a | n/a | 29.43M | 22.15M | 19.36M | 21.89M | 18.89M | 18.38M | 16.31M |
Gross Profit | n/a | n/a | -611K | -77.05M | -632K | 7.5M | n/a | n/a | n/a | -599K | n/a | n/a | n/a | n/a | n/a | -29.3M | -21.61M | -10.59M | -18.15M | -10.77M | -16.16M | -11.95M |
Operating Income | -123.16M | -112.33M | -109.77M | -96.34M | -94.23M | -72.74M | -77.48M | -73.68M | -69.1M | -59.04M | -53.7M | -55.68M | -55.62M | -49.05M | -43.33M | -38.13M | -30.32M | -17.37M | -24.84M | -15.6M | -22.5M | -16.06M |
Interest Income | 12.15M | 6.91M | 6.21M | 6.21M | 7.2M | 8.08M | 9.42M | 10.33M | 10.84M | 11.36M | 8.69M | 6.98M | 6.52M | 5.42M | 4.46M | 3.07M | 816K | 368K | 263K | 76K | 72K | 146K |
Pretax Income | -111.32M | -104.87M | -104.72M | -90.22M | -85.33M | -64.62M | -69.53M | -63.11M | -58.26M | -47.52M | -44.95M | -48.62M | -47.68M | -41.44M | -36.26M | -37.74M | 31.2M | -20.06M | -25.08M | -15.65M | -22.33M | -15.83M |
Net Income | -110.74M | -102.3M | -105.26M | -90.9M | -84.71M | -65.05M | -65.69M | -62.79M | -57.92M | -47.93M | -44.74M | -48.46M | -47.46M | -41.73M | -37.4M | -37.15M | -31.16M | -19.67M | -25.56M | -15.45M | -22.11M | -15.76M |
Selling & General & Admin | 23.93M | 23.82M | 22.07M | 19.28M | 19.24M | 19.04M | 18.01M | 16.71M | 19.4M | 14.19M | 12.62M | 12.8M | 11.58M | 9.54M | 8.5M | 8.83M | 8.71M | 6.78M | 6.69M | 4.83M | 6.34M | 4.11M |
Research & Development | 99.22M | 88.51M | 87.7M | 77.05M | 74.99M | 61.2M | 59.47M | 56.97M | 49.7M | 44.25M | 41.08M | 42.88M | 44.04M | 39.52M | 34.83M | 29.43M | 22.15M | 19.36M | 21.89M | 18.89M | 18.38M | 16.31M |
Other Expenses | n/a | n/a | -611K | -77.05M | -632K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -29.43M | -22.15M | -19.36M | -21.89M | -18.89M | -18.38M | -16.31M |
Operating Expenses | 123.16M | 112.33M | 109.16M | 19.28M | 93.6M | 80.24M | 77.48M | 73.68M | 69.1M | 58.44M | 53.7M | 55.68M | 55.62M | 49.05M | 43.33M | 8.83M | 8.71M | 6.78M | 6.69M | 4.83M | 6.34M | 4.11M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -599K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 123.16M | 112.33M | 109.77M | 96.34M | 94.23M | 80.24M | 77.48M | 73.68M | 69.1M | 59.04M | 53.7M | 55.68M | 55.62M | 49.05M | 43.33M | 38.26M | 30.85M | 26.14M | 28.58M | 23.72M | 24.72M | 20.42M |
Income Tax Expense | -585K | -2.57M | 538K | 677K | -626K | 427K | -3.85M | -320K | -333K | 412K | -205K | -157K | -220K | 290K | 1.14M | -587K | 62.36M | -394K | 484K | -205K | -217K | -68K |
Shares Outstanding (Basic) | 99.61M | 87.35M | 79.25M | 79.25M | 78.95M | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 62.54M | 56.19M | 53.06M | 41.19M | 41.19M | 42.09M | 36.82M |
Shares Outstanding (Diluted) | 99.61M | 87.35M | 79.25M | 79.25M | 78.95M | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 65.47M | 56.19M | 54.85M | 41.19M | 42.27M | 42.09M | 36.82M |
EPS (Basic) | -1.11 | -1.17 | -1.31 | -1.15 | -1.07 | -0.83 | -0.84 | -0.81 | -0.75 | -0.62 | -0.64 | -0.73 | -0.72 | -0.63 | -0.57 | -0.59 | -0.55 | -0.37 | -0.62 | -0.37 | -0.53 | -0.43 |
EPS (Diluted) | -1.11 | -1.17 | -1.31 | -1.15 | -1.07 | -0.83 | -0.84 | -0.81 | -0.75 | -0.62 | -0.64 | -0.73 | -0.72 | -0.63 | -0.57 | -0.57 | -0.55 | -0.36 | -0.62 | -0.37 | -0.53 | -0.43 |
EBITDA | -111.32M | -111.74M | -104.11M | -89.58M | -93.6M | -72.08M | -76.84M | -72.98M | -68.46M | -58.44M | -52.84M | -53.95M | -55.02M | -48.7M | -38.93M | -37.77M | -29.94M | -16.99M | -24.57M | -15.39M | -22.27M | -15.86M |
EBIT | -111.32M | -112.33M | -104.72M | -90.22M | -94.23M | -72.74M | -77.48M | -73.68M | -69.1M | -59.04M | -53.7M | -55.68M | -55.62M | -49.05M | -39.44M | -38.13M | -30.32M | -17.37M | -24.84M | -15.6M | -22.5M | -16.06M |
Depreciation & Amortization | n/a | 587K | 611K | 641K | 632K | 659K | 633K | 700K | 641K | 599K | 851K | 1.73M | 602K | 354K | 515K | 358K | 375K | 376K | 270K | 209K | 231K | 196K |
Add to Watchlist
Select watchlists to add or remove XENE